Stemline Therapeutics Inc

STML

Sector
Healthcare

Industry
Biotechnology

Website
stemline.com




Buy / Sell (dollars)

1 Month

0% 0% Complete (success)
100% 100% Complete (danger)
$0.00
avg. $0.00
$3,130.72
avg. $3,130.72

Buy/Sell Ratio

0

Transactions

1

Filers

1

3 Month

0% 0% Complete (success)
100% 100% Complete (danger)
$0.00
avg. $0.00
$822,772.89
avg. $274,257.63

Buy/Sell Ratio

0

Transactions

11

Filers

4

12 Month

0.6% 0.6% Complete (success)
99.4% 99.4% Complete (danger)
$20,020.00
avg. $1,668.33
$3.544M
avg. $295,354.85

Buy/Sell Ratio

0.006

Transactions

41

Filers

10

24 Month

0.3% 0.3% Complete (success)
99.7% 99.7% Complete (danger)
$20,020.00
avg. $834.17
$6.451M
avg. $268,776.93

Buy/Sell Ratio

0.003

Transactions

75

Filers

10

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers